首页 | 本学科首页   官方微博 | 高级检索  
检索        


Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM
Authors:M J Hussain  M Peakman  H Gallati  S S S Lo  M Hawa  G C Viberti  P J Watkins  R D G Leslie  Professor D Vergani
Institution:(1) Department of Immunology, King's College School of Medicine and Dentistry, Bessemer Road, SE5 9PJ London, UK;(2) Department of Medicine and Diabetes, King's College School of Medicine and Dentistry, London, UK;(3) Unit for Metabolic Medicine,United Medical and Dental Schools, Guy's Hospital, London, UK;(4) Department of Diabetes, St. Bartholomew's Hospital, London, UK;(5) F. Hoffmann-La Roche, Basel, Switzerland
Abstract:Summary To determine whether cytokines could have a role in the development of insulin-dependent diabetes mellitus (IDDM), we measured serum levels of cytokines derived from T helper 1 (interleukin-2 and interferon-gamma), T helper 2 (interleukin-4 and inter-leukin-10) lymphocytes and macrophages (tumour necrosis factor-agr, interleukin-1 agr and interleukin-1 Bgr) in patients before and after the onset of IDDM. Recently diagnosed IDDM patients had significantly higher levels of interleukin-2, interferon-gamma, tumour necrosis factor-agr and interleukin-1 agr than patients with either long-standing IDDM, non-insulin-dependent diabetes (NIDDM), Graves' disease, or control subjects (p<0.05 for all). Compared with control subjects, patients with long-standing IDDM and those with NIDDM had higher interleukin-2 and tumour necrosis factor-agr levels (p<0.01 for all). Interleukin-4 and interleukin-10 were detectable in sera of patients with Graves' disease only, while interleukin-1 Bgr was not detectable in the serum of any control or test subject. To investigate whether high cytokine levels precede the onset of IDDM, we studied 28 non-diabetic identical co-twins of patients with IDDM, followed-up prospectively for up to 6 years after the diagnosis of the index. Levels of tumour necrosis factor-agr and interleukin-1 agr were elevated above the normal range more frequently in the eight twins who developed diabetes than in those 20 who did not (p<0.005). Analysis of T helper 1 and T helper 2 profiles of the twin groups did not reveal a clear difference between prediabetic twins and twins remaining non-diabetic. These results support the notion that T helper 1 lymphocytes may play a role in the development of IDDM. This is associated with release of macrophage-derived cytokines, which is also a feature of the prediabetic period. The lack of evidence of a dominant T helper 1 profile of cytokine release before diabetes onset suggests that additional events, activating this arm of the cellular immune response, are required in the immediate prediabetic period.Abbreviations IL Interleukin - IFN-gamma interferon-gamma - TH T helper - ICA islet-cell antibody - GAD glutamic acid decar-boxylase - IDDM insulin-dependent diabetes mellitus - NIDDM non-insulin-dependent diabetes mellitus - TNF-agr tumour necrosis factor-alpha - CTLL-16 murine cytotoxic cell line
Keywords:Cytokines  T helper subsets  interleukin-2  interferon-gamma" target="_blank">gif" alt="gamma" align="MIDDLE" BORDER="0">  interleukin-1  tumour necrosis factor  prediabetes  identical twins
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号